Evotec SE (EVO) Capital Leases (2009 - 2022)
Evotec SE's (EVO) quarterly Capital Leases came in at -$152.4 million in Q2 2022, up 1.99% quarter-over-quarter from -$155.5 million in Q4 2021.
Analysis
Evotec SE (EVO) Capital Leases (2009 - 2022) Analysis & Trends
Evotec SE has disclosed Capital Leases across 4 years of filings, most recently posting -$152.4 million for Q2 2022.
- In Q2 2022, Capital Leases changed N/A year-over-year to -$152.4 million; the TTM figure through Jun 2022 stood at -$152.4 million (changed N/A YoY), while the FY2021 annual figure was -$160.9 million, changed N/A from the prior year.
- Capital Leases came in at -$152.4 million for Q2 2022 at Evotec SE, up from -$155.5 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of -$152.4 million in Q2 2022 to a low of -$155.5 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -152.44 Mn |
| Dec 31, 2021 | -155.54 Mn |
| Sep 30, 2010 | 61,981.09 |
| Jun 30, 2010 | 91,788.30 |
| Mar 31, 2010 | 149,548.66 |
| Dec 31, 2009 | 194,928.92 |
| Jun 30, 2009 | 276,414.61 |
| Mar 31, 2009 | 359,626.73 |